Section 1115 Waiver Watch: A Look at the Use of Contingency Management to Address Stimulant Use Disorder

Contingency management is an evidence-based psychosocial intervention that uses motivational incentives, such as vouchers or gift cards, to encourage recovery behaviors like stimulant abstinence and treatment session (e.g., cognitive behavioral therapy, group therapy) attendance. The Biden administration has approved four state contingency management waivers (California, Delaware, Montana, and Washington); three additional state contingency management requests…

Read More

RIP Bob Uecker

One of the greatest baseball announcers of all time passed away today. Bob Uecker. The voice of the Milwaukee Brewers. Mr. Baseball. He was certainly the ‘soundtrack to summer’ growing up in Wisconsin. For Brewers fans like me, his calls are those of Brewers history and lore. Brewers TV play-by-play announcer Brian Anderson recalls some…

Read More

Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease

The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. The post Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin…

Read More